Opinion on the re-evaluation of lecithins (e 322) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as food additive for uses in foods for all population groups - Université de Lille
Article Dans Une Revue EFSA Journal Année : 2020

Opinion on the re-evaluation of lecithins (e 322) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as food additive for uses in foods for all population groups

Maged Younes
  • Fonction : Auteur
Gabriele Aquilina
  • Fonction : Auteur
Laurence Castle
  • Fonction : Auteur
Karl-Heinz Engel
  • Fonction : Auteur
Paul Fowler
  • Fonction : Auteur
Maria Jose Frutos Fernandez
  • Fonction : Auteur
Peter Furst
  • Fonction : Auteur
Rainer Gurtler
  • Fonction : Auteur
Trine Husoy
  • Fonction : Auteur
Melania Manco
  • Fonction : Auteur
Wim Mennes
  • Fonction : Auteur
Peter Moldeus
  • Fonction : Auteur
Sabina Passamonti
  • Fonction : Auteur
Romina Shah
  • Fonction : Auteur
Ine Waalkens-Berendsen
  • Fonction : Auteur
Detlef Wolfle
  • Fonction : Auteur
Matthew Wright
  • Fonction : Auteur
Birgit Dusemund
  • Fonction : Auteur
Alicja Mortensen
  • Fonction : Auteur
Stefania Barmaz
  • Fonction : Auteur
Alexandra Tard
  • Fonction : Auteur
Giorgia Vianello
  • Fonction : Auteur
Ursula Gundert-Remy
  • Fonction : Auteur

Résumé

Lecithins (E 322) were re-evaluated in 2017 by the former EFSA Panel on Food Additives and Nutrient sources added to Food (ANS). As follow-up to that assessment, the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of lecithins (E 322) for uses as food additive in food for infants below 16 weeks of age belonging to food categories 13.1.1 and 13.1.5.1 and as carry over in line with Annex III to Regulation (EC) No 1333/2008. In addition, the FAF Panel was requested to address the issues identified during the re-evaluation of the food additive (E 322). The process involved the publication of a call for data to allow the interested business operators to provide the requested information to complete the risk assessment. Based on the information submitted in response to the call for data, the FAF Panel considered it feasible to amend the EU specifications, in particular for the toxic elements arsenic, lead, mercury and introduce new specifications for cadmium and microbiological criteria. The safety issue identified by the ANS Panel in 2017 concerned potential neurodevelopmental effects. For the reason that choline is a precursor of the neurotransmitter acetylcholine, the Panel considered it appropriate to address the safety of lecithins (E 322) as food additive in infant formula used in infants below the age of 16 weeks by comparing the concentration of choline in human milk with that in the formula. The Panel concluded that the intake of lecithins (E 322) as a food additive in infant formula belonging to FC 13.1.1 or in food for special medical purposes belonging to FC 13.1.5.1 does not raise safety concerns up to the maximum permitted level (MPL) of lecithins (E 322).
Fichier principal
Vignette du fichier
EFSA Journal - 2020 - - Opinion on the re‐evaluation of lecithins E 322 as a food additive in foods for infants below 16.pdf (3.82 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04387759 , version 1 (11-01-2024)

Licence

Identifiants

Citer

Maged Younes, Gabriele Aquilina, Laurence Castle, Karl-Heinz Engel, Paul Fowler, et al.. Opinion on the re-evaluation of lecithins (e 322) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as food additive for uses in foods for all population groups. EFSA Journal, 2020, EFSA Journal, 18, pp.e06266. ⟨10.2903/j.efsa.2020.6266⟩. ⟨hal-04387759⟩

Collections

RIIP UNIV-LILLE
2 Consultations
1 Téléchargements

Altmetric

Partager

More